JJ
CLSD

Johnson & Johnson’s Clearside Biomedical CLSD Stock Holding History

Johnson & Johnson’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,499
Closed -$105K – 21
2024
Q3 		$105K Buy
+5,499
New +$93.9K 0.02% 19
2024
Q2 		– Sell
-11,309
Closed -$260K – 21
2024
Q1 		$260K Hold
11,309
– – 0.01% 20
2023
Q4 		$198K Hold
11,309
– – ﹤0.01% 20
2023
Q3 		$148K Hold
11,309
– – 0.05% 20
2023
Q2 		$190K Hold
11,309
– – 0.06% 18
2023
Q1 		$176K Hold
11,309
– – 0.06% 19
2022
Q4 		$190K Buy
+11,309
New +$204K 0.06% 18

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Johnson & Johnson's CLSD Position: Q4 2024 in Review

Johnson & Johnson sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 5,499 shares — an estimated $105K sold.

Johnson & Johnson first reported a position in CLSD in Q4 2022 and held it in 7 quarters. The position peaked at $260K in Q1 2024. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • Johnson & Johnson reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • Johnson & Johnson sold 5,499 Clearside Biomedical shares in Q4 2024, an estimated $105K.
  • Johnson & Johnson first reported a position in Clearside Biomedical in Q4 2022 and held it in 7 quarters.
  • Johnson & Johnson's Clearside Biomedical position peaked at $260K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on Johnson & Johnson's 13F filing for Q4 2024, filed 13 Feb 2025.